EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans

Janardan P Pandey, Paul J Nietert, Aryan M Namboodiri, David A Bennett, Lisa L Barnes

Immunogenetics · 2025

DOI: 10.1007/s00251-024-01358-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunogenetics, 2025. Verfasst von Janardan P Pandey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC, 29425-2230, USA. pandeyj@musc.edu. Hauptthemen laut MEDLINE: Alzheimer Disease, Receptors, IgG, Black or African American, Epistasis, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging, Medical University of South Carolina.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome-wide association studies (GWAS) of Alzheimer’s disease (AD) have identified a large number of susceptibility genes, but most of AD heritability remains unexplained, implying the existence of additional genes. Furthermore, the majority of the GWAS have been conducted in people of European descent, and the genes important for AD susceptibility in people of African descent have been underexplored. In this hypothesis-generating prospective cohort study, we genotyped 191 African Americans (AAs) from three longitudinal cohorts on aging for the IgG3 allotype GM6, which is expressed exclusively in people of African descent, and assessed its interaction with IGHG , FCGRIIB , and HLA-DRB1 genes. Cox proportional hazards modeling showed that GM6 by itself was not significantly associated with AD development. However, there was evidence of epistatic interaction: The risk of developing AD associated with GM6 positivity was significantly different ( p = 0.0098) in non-GM17/GM17 participants compared with GM 17/GM17 participants. Specifically, in non-GM17/GM17 participants, the risk of AD was over fourfold higher in GM6-positive participants compared with GM 6-negative participants (HR = 4.63). Similarly, risk of developing AD associated with GM6 positivity was marginally different in non-FCGRIIB TT participants compared with FCGRIIB TT participants. In non-FCGRIIB TT participants, the risk of developing AD was over twofold higher in GM6-positive participants compared with GM6-negative participants (HR = 2.44). This is the first report suggesting that immunoglobulin GM allotypes might play a role in AD etiology among AAs; however, since this was largely a hypothesis-generating study, replication in larger cohorts would be required to confirm this finding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseReceptors, IgGBlack or African AmericanEpistasis, GeneticGenetic Predisposition to DiseaseHumansFemaleMaleAgedImmunoglobulin Gm AllotypesAged, 80 and overGenome-Wide Association StudyMiddle AgedGenotypeHLA-DRB1 ChainsImmunoglobulin Heavy Chains

Stichwörter der Autor:innen

FCGRIIBHLA-DRB1PILRAAlzheimer’s diseaseGM (γ marker)Heritability

Substanzen

Receptors, IgGImmunoglobulin Gm AllotypesHLA-DRB1 ChainsImmunoglobulin Heavy Chains

Autor:innen und Institutionen

  • Department of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC, 29425-2230, USA. pandeyj@musc.edu.
  • Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • Department of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC, 29425-2230, USA.
  • Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.

Förderung

  • NIA NIH HHS
  • National Institute on Aging
  • Medical University of South Carolina

Zitieren

APA

Pandey, J. P., Nietert, P. J., Namboodiri, A. M., Bennett, D. A., & Barnes, L. L. (2025). Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans. Immunogenetics. https://doi.org/10.1007/s00251-024-01358-4

Vancouver

Pandey JP, Nietert PJ, Namboodiri AM, Bennett DA, Barnes LL. Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans. Immunogenetics. 2025. doi:10.1007/s00251-024-01358-4

BibTeX
@article{Pandey2025,
  author = {Pandey, Janardan P and Nietert, Paul J and Namboodiri, Aryan M and Bennett, David A and Barnes, Lisa L},
  title = {Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans},
  journal = {Immunogenetics},
  year = {2025},
  doi = {10.1007/s00251-024-01358-4}
}
Kostenlos starten →